Back to search

Boston University

Development of drug-stabilizable molecular tools for modulating protein activity and intracellular signaling

Abstract

dc:description.abstract

Nature has evolved elegant mechanisms to regulate the activities of biomolecules that make up sophisticated cellular processes. In order to untangle complex biological systems, researchers have developed a wide variety of molecular tools that allow them to study individual biological processes in isolation, such as small-molecule dimerizers that are used to precisely determine when protein interactions occur. There remains a constant need for new orthogonal biological parts to simulate cellular processes for basic biology and therapeutic applications. In this Thesis, we develop a variety of protein-based tools using NS3, a protease derived from hepatitis C virus. Due to its high substrate specificity and availability of clinically approved inhibitors, NS3 has been used in previous works to make drug-controllable tools. We first utilize NS3 to convert nanobodies into single-chain binders with drug-controllable binding activity. We demonstrate that this engineering strategy is generalizable to multiple nanobodies, and that these engineered nanobodies can be used to control endogenous signaling activity. We then develop a genetically encoded inhibitor of Notch signaling with drug-dependent stability using NS3. We show that this inhibitor can nearly fully repress transcription mediated by Notch 1 intracellular domain in a drug-dependent manner and is also effective against transcription mediated by Notch 2 and Notch 3 intracellular domains. Finally, we explore a budding approach to targeted protein degradation that directly engages the proteasome and bypasses ubiquitination. We demonstrate that our design, which consists of a proteasome-binding nanobody and NS3, can be used to degrade proteins in a drug-dependent manner. We also show various ways that this nanobody can be used to make new tools. With this work, we hope to not only contribute to the molecular toolbox, but also to devise new protein engineering strategies that will inform future tool designs.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Boston University
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Le, Quan
Advisor dc:contributor.advisor
  • Ngo, John T.
ORCID dc:identifier.orcid

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52983

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Le, Quan. Development of drug-stabilizable molecular tools for modulating protein activity and intracellular signaling. doctoral thesis, Boston University, 2026. https://hdl.handle.net/2144/52983